Relmada Therapeutics (RLMD) Accounts Payables (2012 - 2026)
Relmada Therapeutics (RLMD) posted Accounts Payables of $2.41 million for Q2 2026, up 76.9% from $1.36 million a year earlier but down 58.0% from the prior quarter.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Accounts Payables (2012 - 2026) Analysis & Trends
At the end of FY2025, Relmada Therapeutics' Accounts Payables came in at $1.57 million, down 62.0% from FY2024.
- Annual Accounts Payables shows a five-year compound annual growth rate of -28.4% (FY2020 to FY2025).
- In prior years, Relmada Therapeutics' Accounts Payables was $4.13 million in FY2024 (+17.8%), $3.51 million in FY2023 (-33.4%), $5.26 million in FY2022 (-53.0%) and $11.19 million in FY2021 (+34.1%).
- Quarterly Accounts Payables has run from a low of $1.27 million in Q1 2025 to a high of $12.71 million in Q3 2021 over five years.
- On a year-over-year basis, Accounts Payables increased in three of the last eight quarters, with growth averaging 18.4%.
- The strongest year-over-year quarter for Accounts Payables in the past five years was Q1 2026, with growth of 353.1%; the weakest was Q1 2025, with a decline of 75.6%.
- According to Business Quant data, Accounts Payables for the three prior quarters was $5.73 million (Q1 2026), $1.57 million (Q4 2025) and $1.45 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Relmada Therapeutics | 397.88 Mn | 397.88 Mn | - | 2.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.41 Mn |
| Mar 31, 2026 | 5.73 Mn |
| Dec 31, 2025 | 1.57 Mn |
| Sep 30, 2025 | 1.45 Mn |
| Jun 30, 2025 | 1.36 Mn |
| Mar 31, 2025 | 1.27 Mn |
| Dec 31, 2024 | 4.13 Mn |
| Sep 30, 2024 | 2.35 Mn |
| Jun 30, 2024 | 4.17 Mn |
| Mar 31, 2024 | 5.19 Mn |
| Dec 31, 2023 | 3.51 Mn |
| Sep 30, 2023 | 5.57 Mn |
| Jun 30, 2023 | 4.85 Mn |
| Mar 31, 2023 | 4.42 Mn |
| Dec 31, 2022 | 5.26 Mn |
| Sep 30, 2022 | 10.43 Mn |
| Jun 30, 2022 | 7.54 Mn |
| Mar 31, 2022 | 10.67 Mn |
| Dec 31, 2021 | 11.19 Mn |
| Sep 30, 2021 | 12.71 Mn |
API Access
Relmada Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();